SlideShare a Scribd company logo
IMMUNOGLOBULINS
STRUCTURE AND FUNCTION
IMMUNOGLOBULINS
Definition
Glycoprotein molecules that
are present on B cells (BCR) or
produced by plasma cells
(usually referred to as
antibodies) in response to an
immunogen
 Antibodies production is the sole function
of the B cells
 Not toxic or destructive, bind the
pathogen tightly and target destructive
components of the immune system
 Antibodies are useful in the defense
against extracellular pathogens
 Antibodies are secreted in the secondary
lymphoid organs and in bone marrow and
find their way to the extracellular spaces
 During the course of an infection
antibody effectiveness improves steadily
PHASES OF B CELL RESPONSE !
IMMUNOGLOBULIN STRUCTURE
• 2x Heavy chain (light blue)
• 2x light chain (dark blue)
• Variable regions  antigen binding
• Constant regions
hinge region
carbohydrate
disulfide bond
CH
1
VL
CL
VH
CH2 CH3
!
Ribbon structure of IgG
Antibody
BCR (B cell receptor)
!!
MEMBRANE BOUND!
Associated chains
for signaling
Transmembrane
domain
Cytoplasmic
domain
Antigen recognition and B cell
activation
SOLUBLE (freely circulating)
Antigen recognition and effector
functions.
Produced by plasma cells
s
s
s
s
s
s
s
s
s s
s s
CH2
CH3
s
s
s
s
s
s
s
s
s
s
VL
VH
CL
CH1
s
s
s
s
s
s
s
s
s
s
effektor funkciók
konstans domének
antigénkötés
variábilis dom ének
ANTIBODY DOMAINS AND THEIR FUNCTIONS
!
!
Constant domain
Effector functions
Antigen recognition
Variable domain
mIg = BCR
Associated chains providing
signaling capacity
!
B cell
B CELL ACTIVATION
BCR oligomerization results in B cell
activation, proliferation and differentiation
!
FLEXIBILITY OF ANTIBODIES
FEATURES OF ANTIBODY-ANTIGEN INTERACTION
Valency: numbers of antigen
epitopes an antibody binds
Affinity: the strength of
interaction between a specific
antigen and one binding site
of the antibody
Avidity: The overall strength
of binding at multiple sites in
an antibody
ANTIGEN BINDING
Antigen Binding
Fragment (Fab)
Complement binding site
Placental transfer
Constant fragment (Fc)
Binding to Fc receptors
on phagocytic cells
Sequence variability of H/L-
chain constant regions
VARIABILITY IN DIFFERENT REGIONS OF THE Ig
DETERMINES Ig SPECIFICITY OR CLASS
isotype
Sequence variability of H/L-
chain variable regions
Idiotype
DIFFERENT VARIABLE REGIONS 
DIFFERENT ANTIGEN-BINDING SITES 
DIFFERENT SPECIFICITIES
ANTIGEN BINDING FRAGMENT (Fab)
CONTAINS HYPERVARIABLE REGIONS
DNA recombination of gene
segments encoding these
regions (variable heavy and
light polypeptide chains) gives
a huge number of variability
during B cell development in
the bone marrow.
Aka. Somatic recombination
COMPLEMENTARY DETERMINING REGIONS (CDR)
Epitope
CDR1
CDR2
CDR3
CDR1
CDR2
CDR3
Light
chain
Heavy
chain
Sequence variability of H/L-
chain constant regions
VARIABILITY IN DIFFERENT REGIONS OF THE Ig
DETERMINES Ig SPECIFICITY OR CLASS
Sequence variability of H/L-
chain constant regions
Isotype
• IgG - gamma (γ) heavy chains
• IgM - mu (μ) heavy chains
• IgA - alpha (α) heavy chains
• IgD - delta (δ) heavy chains
• IgE - epsilon (ε) heavy chains
HUMAN IMMUNOGLOBULIN CLASSES
ENCODED BY DIFFERENT STRUCTURAL GENE SEGMENTS (ISOTYPES)
• kappa (κ)
• lambda (λ)
Heavy chain types:
Light chain types:
!
ISOTYPE SWITCHING
PHASES OF B CELL RESPONSE !
Ig isotype Serum
concentration
Characteristics, functions
12-14 mg/ml
 Major isotype of secondary
(memory) immune response
 Complexed with antigen activates
effector functions (Fc-receptor
binding, complement activation
Trace
amounts
 The first isotype in B-lymphocyte
membrane
 Function in serum is not known
Trace
amounts
 Major isotype in protection against
parasites
 Mediator of allergic reactions (binds
to basophils and mast cells)
3-3,5 mg/ml
 Major isotype of secretions (saliva,
tear, milk)
 Protection of mucosal surfaces
1-2 mg/ml
 Major isotype of primary immune
responses
 Complexed with antigen activates
complement
 Agglutinates microbes
 The monomeric form is expressed in
B-lymphocyte membrane as antigen
binding receptor
MAIN CHARACTERISTICS OF ANTIBODY ISOTYPES
MAIN CHARACTERISTICS OF ANTIBODY ISOTYPES
Ig. Concentration
napok
primer response
„A
” antig n
é
IgM
IgG
IgA
IgE
Szekunder ’lasyecondary respo
„A
” és
antigén
„B
”
5 10 15 20 25 30
IgM
secondary response against
antigen A
Primary response
against antigen A
Level of antibodies
napok
primary response
against antigen B
Antigen A
Days
Antigen A and B
ANTIBODY PRODUCTION DURING THE
PRIMARY AND THE SECONDARY IMMUNE RESPONSES
ANTIBODY PRODUCTION DURING THE
PRIMARY AND THE SECONDARY IMMUNE RESPONSE !
EFFECTOR FUNCTIONS OF ANTIBODIES
Antibody-mediated immune responses
• NEUTRALIZATION
• OPSONIZATION
ADCC
MAST CELL DEGRANULATION
• COMPLEMENT FIXATION
!
!
NEUTRALIZATION
Covering of the pathogen’s surface
prevents replication and growth
Antigen binding
Complement binding site
Placental transfer
Binding to Fc receptors
OPSONIZATION
Flagging a pathogen
Antigen binding portion (Fab)
binds the pathogen, the Fc
region binds phagocytic cells
Fc-receptors speeding up the
process of phagocytosis
Antibody Dependent Cellular Cytotoxicity
(ADCC)
(A) High-affinity FcRs on the surface of the cell bind monomeric
Ig before it binds to antigen. (mast cell)
(B) Low-affinity FcRs bind multiple Igs that have already bound to
a multivalent antigen. (macrophage, NK cell)
MAST CELL DEGRANULATION
FcεRI
+
IgEs
Antigen binding
Complement binding site
Placental transfer
Binding to Fc receptors
COMPLEMENT FIXATION
IgM and IgGs activate the classical pathway of
the complement system
Bacterium
Complement receptor
Macrophage
OPSONIZATION BY C3b
C3b
IMMUNOGLOBULIN ISOTYPES HAVE EACH
THEIR SPECIFIC CAPABILITIES
Antigen binding
Complement binding site
Placental transfer
Binding to Fc receptors
FcRn on the placenta
facilitate the transfer of
maternal IgG to the fetus’s
circulation
IgG
IgM
IgA
AFTER BIRTH
breast milk
IgA
0
100%
( adult)
3 3
year
2 5
4
6 adult
9 1
month
maternal IgG
BEFORE BIRTH
PRODUCTION OF IMMUNOGLOBULINS
 IgG transport is so efficient that at birth babies have as high a level of IgG in
their plasma as their mothers
 These transfers are a form of passive immunization. The babies protection by
IgG and IgA is against those pathogen that the mother has mounted
 At the first year (esp.3-12m) maternal IgGs are catabolized and breast feeding
diminishes so babies become most susceptible/vulnerable to infections
Pathological consequences of placental
transport of IgG
(hemolytic disease of the newborn)
Passive anti-D IgG
anti-Rh
IgM
DIMERIC IgA
IgA dimers are in the highly vulnerable mucosal epithelia lining the
GI, respiratory, urinary and genital tracts, the eyes, nose and throat
(Transcytosis)

More Related Content

Similar to IMMUNOGLOBULINS.ppt

Antibody therapy and engineering
Antibody therapy and engineeringAntibody therapy and engineering
Antibody therapy and engineering
Grace Felciya
 
BCM 217 Lecture Series 2021.pptx
BCM 217 Lecture Series 2021.pptxBCM 217 Lecture Series 2021.pptx
BCM 217 Lecture Series 2021.pptx
EnockKizito1
 
Strucure, functions and genetics of immunoglobulins
Strucure, functions and genetics of immunoglobulinsStrucure, functions and genetics of immunoglobulins
Strucure, functions and genetics of immunoglobulins
JESSE OWAKI
 
Immunoglobulins- Explained
Immunoglobulins- ExplainedImmunoglobulins- Explained
Immunoglobulins- Explained
Sabahat H Zaidi
 
06. ag receptor immunoglobulins
06. ag receptor   immunoglobulins06. ag receptor   immunoglobulins
06. ag receptor immunoglobulins
Yahyea Laskar
 
Antibody structure and the generation of b cell
Antibody structure and the generation of b  cellAntibody structure and the generation of b  cell
Antibody structure and the generation of b cell
Cae Upr Cayey
 
Immuology
ImmuologyImmuology
Immuology
AhmedRiyadh17
 
Immunogloblin.pptx
Immunogloblin.pptxImmunogloblin.pptx
Immunogloblin.pptx
geofreyjaphet1
 
Immunoglobulins 2001
Immunoglobulins 2001Immunoglobulins 2001
Immunoglobulins 2001
Kinza Ayub
 
Antibody deepa babin
Antibody deepa babinAntibody deepa babin
Antibody1111111111111111111
Antibody1111111111111111111Antibody1111111111111111111
Antibody1111111111111111111
braveheart1212
 
Structure and function of immunoglobulins(antibodies) Likhith K
Structure and function of immunoglobulins(antibodies) Likhith KStructure and function of immunoglobulins(antibodies) Likhith K
Structure and function of immunoglobulins(antibodies) Likhith K
LIKHITHK1
 
Antibody Structure
Antibody StructureAntibody Structure
Antibody Structure
Palwasha44
 
Organization and expression of immunoglobulin genes
Organization and expression of immunoglobulin genesOrganization and expression of immunoglobulin genes
Organization and expression of immunoglobulin genes
Dr. Dinesh C. Sharma
 
Antibodies
AntibodiesAntibodies
Antibodies
Naeem Ahmed
 
Antibody generation
Antibody generationAntibody generation
Antibody generation
Muthuselvi selvaraj
 
Antibodies immunoglobulins
Antibodies   immunoglobulinsAntibodies   immunoglobulins
Antibodies immunoglobulins
Meenakshi Sharma
 
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
Shrutkirtigupta1
 
Antibodies
AntibodiesAntibodies
Antibodies
EstherShoba1
 
Antibodies
AntibodiesAntibodies
Antibodies
Deepak Chaudhary
 

Similar to IMMUNOGLOBULINS.ppt (20)

Antibody therapy and engineering
Antibody therapy and engineeringAntibody therapy and engineering
Antibody therapy and engineering
 
BCM 217 Lecture Series 2021.pptx
BCM 217 Lecture Series 2021.pptxBCM 217 Lecture Series 2021.pptx
BCM 217 Lecture Series 2021.pptx
 
Strucure, functions and genetics of immunoglobulins
Strucure, functions and genetics of immunoglobulinsStrucure, functions and genetics of immunoglobulins
Strucure, functions and genetics of immunoglobulins
 
Immunoglobulins- Explained
Immunoglobulins- ExplainedImmunoglobulins- Explained
Immunoglobulins- Explained
 
06. ag receptor immunoglobulins
06. ag receptor   immunoglobulins06. ag receptor   immunoglobulins
06. ag receptor immunoglobulins
 
Antibody structure and the generation of b cell
Antibody structure and the generation of b  cellAntibody structure and the generation of b  cell
Antibody structure and the generation of b cell
 
Immuology
ImmuologyImmuology
Immuology
 
Immunogloblin.pptx
Immunogloblin.pptxImmunogloblin.pptx
Immunogloblin.pptx
 
Immunoglobulins 2001
Immunoglobulins 2001Immunoglobulins 2001
Immunoglobulins 2001
 
Antibody deepa babin
Antibody deepa babinAntibody deepa babin
Antibody deepa babin
 
Antibody1111111111111111111
Antibody1111111111111111111Antibody1111111111111111111
Antibody1111111111111111111
 
Structure and function of immunoglobulins(antibodies) Likhith K
Structure and function of immunoglobulins(antibodies) Likhith KStructure and function of immunoglobulins(antibodies) Likhith K
Structure and function of immunoglobulins(antibodies) Likhith K
 
Antibody Structure
Antibody StructureAntibody Structure
Antibody Structure
 
Organization and expression of immunoglobulin genes
Organization and expression of immunoglobulin genesOrganization and expression of immunoglobulin genes
Organization and expression of immunoglobulin genes
 
Antibodies
AntibodiesAntibodies
Antibodies
 
Antibody generation
Antibody generationAntibody generation
Antibody generation
 
Antibodies immunoglobulins
Antibodies   immunoglobulinsAntibodies   immunoglobulins
Antibodies immunoglobulins
 
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
(POLYREACTIVE ANTIBODIES IN HEALTH AND DISEASE).pptx
 
Antibodies
AntibodiesAntibodies
Antibodies
 
Antibodies
AntibodiesAntibodies
Antibodies
 

Recently uploaded

vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 

Recently uploaded (20)

vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 

IMMUNOGLOBULINS.ppt

  • 2. IMMUNOGLOBULINS Definition Glycoprotein molecules that are present on B cells (BCR) or produced by plasma cells (usually referred to as antibodies) in response to an immunogen
  • 3.  Antibodies production is the sole function of the B cells  Not toxic or destructive, bind the pathogen tightly and target destructive components of the immune system  Antibodies are useful in the defense against extracellular pathogens  Antibodies are secreted in the secondary lymphoid organs and in bone marrow and find their way to the extracellular spaces  During the course of an infection antibody effectiveness improves steadily
  • 4. PHASES OF B CELL RESPONSE !
  • 5. IMMUNOGLOBULIN STRUCTURE • 2x Heavy chain (light blue) • 2x light chain (dark blue) • Variable regions  antigen binding • Constant regions hinge region carbohydrate disulfide bond CH 1 VL CL VH CH2 CH3 !
  • 7. Antibody BCR (B cell receptor) !! MEMBRANE BOUND! Associated chains for signaling Transmembrane domain Cytoplasmic domain Antigen recognition and B cell activation SOLUBLE (freely circulating) Antigen recognition and effector functions. Produced by plasma cells
  • 8. s s s s s s s s s s s s CH2 CH3 s s s s s s s s s s VL VH CL CH1 s s s s s s s s s s effektor funkciók konstans domének antigénkötés variábilis dom ének ANTIBODY DOMAINS AND THEIR FUNCTIONS ! ! Constant domain Effector functions Antigen recognition Variable domain
  • 9. mIg = BCR Associated chains providing signaling capacity !
  • 10. B cell B CELL ACTIVATION BCR oligomerization results in B cell activation, proliferation and differentiation !
  • 12. FEATURES OF ANTIBODY-ANTIGEN INTERACTION Valency: numbers of antigen epitopes an antibody binds Affinity: the strength of interaction between a specific antigen and one binding site of the antibody Avidity: The overall strength of binding at multiple sites in an antibody
  • 13. ANTIGEN BINDING Antigen Binding Fragment (Fab) Complement binding site Placental transfer Constant fragment (Fc) Binding to Fc receptors on phagocytic cells
  • 14. Sequence variability of H/L- chain constant regions VARIABILITY IN DIFFERENT REGIONS OF THE Ig DETERMINES Ig SPECIFICITY OR CLASS isotype Sequence variability of H/L- chain variable regions Idiotype
  • 15. DIFFERENT VARIABLE REGIONS  DIFFERENT ANTIGEN-BINDING SITES  DIFFERENT SPECIFICITIES
  • 16. ANTIGEN BINDING FRAGMENT (Fab) CONTAINS HYPERVARIABLE REGIONS DNA recombination of gene segments encoding these regions (variable heavy and light polypeptide chains) gives a huge number of variability during B cell development in the bone marrow. Aka. Somatic recombination
  • 17. COMPLEMENTARY DETERMINING REGIONS (CDR) Epitope CDR1 CDR2 CDR3 CDR1 CDR2 CDR3 Light chain Heavy chain
  • 18. Sequence variability of H/L- chain constant regions VARIABILITY IN DIFFERENT REGIONS OF THE Ig DETERMINES Ig SPECIFICITY OR CLASS Sequence variability of H/L- chain constant regions Isotype
  • 19. • IgG - gamma (γ) heavy chains • IgM - mu (μ) heavy chains • IgA - alpha (α) heavy chains • IgD - delta (δ) heavy chains • IgE - epsilon (ε) heavy chains HUMAN IMMUNOGLOBULIN CLASSES ENCODED BY DIFFERENT STRUCTURAL GENE SEGMENTS (ISOTYPES) • kappa (κ) • lambda (λ) Heavy chain types: Light chain types: !
  • 21. PHASES OF B CELL RESPONSE !
  • 22. Ig isotype Serum concentration Characteristics, functions 12-14 mg/ml  Major isotype of secondary (memory) immune response  Complexed with antigen activates effector functions (Fc-receptor binding, complement activation Trace amounts  The first isotype in B-lymphocyte membrane  Function in serum is not known Trace amounts  Major isotype in protection against parasites  Mediator of allergic reactions (binds to basophils and mast cells) 3-3,5 mg/ml  Major isotype of secretions (saliva, tear, milk)  Protection of mucosal surfaces 1-2 mg/ml  Major isotype of primary immune responses  Complexed with antigen activates complement  Agglutinates microbes  The monomeric form is expressed in B-lymphocyte membrane as antigen binding receptor MAIN CHARACTERISTICS OF ANTIBODY ISOTYPES
  • 23. MAIN CHARACTERISTICS OF ANTIBODY ISOTYPES
  • 24. Ig. Concentration napok primer response „A ” antig n é IgM IgG IgA IgE Szekunder ’lasyecondary respo „A ” és antigén „B ” 5 10 15 20 25 30 IgM secondary response against antigen A Primary response against antigen A Level of antibodies napok primary response against antigen B Antigen A Days Antigen A and B ANTIBODY PRODUCTION DURING THE PRIMARY AND THE SECONDARY IMMUNE RESPONSES
  • 25. ANTIBODY PRODUCTION DURING THE PRIMARY AND THE SECONDARY IMMUNE RESPONSE !
  • 26. EFFECTOR FUNCTIONS OF ANTIBODIES Antibody-mediated immune responses • NEUTRALIZATION • OPSONIZATION ADCC MAST CELL DEGRANULATION • COMPLEMENT FIXATION ! !
  • 27. NEUTRALIZATION Covering of the pathogen’s surface prevents replication and growth
  • 28. Antigen binding Complement binding site Placental transfer Binding to Fc receptors
  • 29. OPSONIZATION Flagging a pathogen Antigen binding portion (Fab) binds the pathogen, the Fc region binds phagocytic cells Fc-receptors speeding up the process of phagocytosis
  • 30. Antibody Dependent Cellular Cytotoxicity (ADCC)
  • 31. (A) High-affinity FcRs on the surface of the cell bind monomeric Ig before it binds to antigen. (mast cell) (B) Low-affinity FcRs bind multiple Igs that have already bound to a multivalent antigen. (macrophage, NK cell) MAST CELL DEGRANULATION FcεRI + IgEs
  • 32. Antigen binding Complement binding site Placental transfer Binding to Fc receptors
  • 33. COMPLEMENT FIXATION IgM and IgGs activate the classical pathway of the complement system
  • 35. IMMUNOGLOBULIN ISOTYPES HAVE EACH THEIR SPECIFIC CAPABILITIES
  • 36. Antigen binding Complement binding site Placental transfer Binding to Fc receptors FcRn on the placenta facilitate the transfer of maternal IgG to the fetus’s circulation
  • 37. IgG IgM IgA AFTER BIRTH breast milk IgA 0 100% ( adult) 3 3 year 2 5 4 6 adult 9 1 month maternal IgG BEFORE BIRTH PRODUCTION OF IMMUNOGLOBULINS  IgG transport is so efficient that at birth babies have as high a level of IgG in their plasma as their mothers  These transfers are a form of passive immunization. The babies protection by IgG and IgA is against those pathogen that the mother has mounted  At the first year (esp.3-12m) maternal IgGs are catabolized and breast feeding diminishes so babies become most susceptible/vulnerable to infections
  • 38. Pathological consequences of placental transport of IgG (hemolytic disease of the newborn) Passive anti-D IgG anti-Rh IgM
  • 39. DIMERIC IgA IgA dimers are in the highly vulnerable mucosal epithelia lining the GI, respiratory, urinary and genital tracts, the eyes, nose and throat (Transcytosis)